Results 231 to 240 of about 121,085,656 (267)

miRNA-mediated cell-to-cell communications boost DNA repair during the radioadaptive response. [PDF]

Nucleic Acids Res
Domínguez-Pérez MDC, Fernández-Ávila MJ, González-Vinceiro L, Zannini L, Peinado H, González-Prieto R, García-Rodríguez N, Huertas P.   +7 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Lipid metabolic reprogramming in clear cell renal cell carcinoma: focus on high-density lipoprotein-related pathways. [PDF]

Oncol Rev
Wu L, Xue H, Wu Y, Shen N, Yang Z, Gao L, Ma W, Wang C.   +7 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Reduced <i>VEPH1</i> expression is associated with an invasive phenotype and poor prognosis in clear cell renal cell carcinoma. [PDF]

Transl Androl Urol
Li Y, Jin H, Gao C, Wang Y, Li S.
europepmc   +1 more source

Should Metastatic Site Inform First-Line Therapy in Clear Cell Renal Cell Carcinoma? [PDF]

Target Oncol
Liu MA, Miyazaki K, Runcie K, Cash H, Meng L.   +4 more
europepmc   +1 more source

Histologic Heterogeneity of Metastases in Clear Cell Renal Cell Carcinoma with Sarcomatoid Differentiation. [PDF]

J Clin Med
Berry K, Skelton WP, Karabinus M, Monda S, Tandon R, Frierson H, May AM.   +6 more
europepmc   +1 more source

Synchronous Duodenal and Pancreatic Metastases From Clear Cell Renal Cell Carcinoma 18 Years After Nephrectomy: A Case Report. [PDF]

Clin Case Rep
Kulkarni A, Sapkota S, Vemula SSM, Motkur S, Jha A, Sharma RP, Rayamajhi S.   +6 more
europepmc   +1 more source